Source: Zacks

Bayer : Bayer Obtains Full FDA Approval for Oncology Drug Vitrakvi

The FDA converts its accelerated approval to full approval for BAYRY's oncology drug, Vitrakvi, on positive data from confirmatory studies.

Read full article »
Annual Revenue
$50-100B
Employees
50-100K
William N. Anderson's photo - CEO of Bayer

CEO

William N. Anderson

CEO Approval Rating

63/100

Read more